117
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

In silico analysis of anti-leukemia immune response and immune evasion in acute myeloid leukemia

, , , , , & show all
Pages 2493-2496 | Received 17 Sep 2017, Accepted 23 Jan 2018, Published online: 12 Feb 2018

References

  • Senovilla L, Vacchelli E, Galon J, et al. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. OncoImmunology. 2012;1:1323–1343.
  • Riddell SR, Berger C, Murata M, et al. The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. Blood Rev. 2003;17:153–162.
  • Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer. 2004;4:371–380.
  • Teague RM, Kline J. Immune evasion in acute myeloid leukemia: current concepts and future directions. J Immunother Cancer. 2013;1:13.
  • Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381:484–495.
  • Bullinger L, Döhner K, Döhner H. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. J Clin Oncol. 2017;35:934–946.
  • Thomas X, Chelghoum Y, Cannas G, et al. Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making? Clin Lymphoma Myeloma Leuk. 2011;11:342–349.
  • Ley T, Miller J, Ding CL, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059–2074.
  • Deng M, Brägelmann J, Schultze JL, et al. Web-TCGA: an online platform for integrated analysis of molecular cancer data sets. BMC Bioinformatics. 2016;17:72.
  • Rooney MS, Shukla SA, Wu CJ, et al. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160:48–61.
  • Davids MS, Kim HT, Bachireddy P, et al. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016;375:143–153.
  • KamimuraMiyamoto T, Harada TM, Akashi K. Advances in therapies for acute promyelocytic leukemia. Cancer Sci. 2011;102:1929–1937.
  • RobinAndreu-Gallien MJ, Schlageter M-, Bengoufa H, et al. Frequent antibody production against RARα in both APL mice and patients. Blood. 2006;108:1972–1974.
  • Padua RA, Larghero J, Robin M, et al. PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat Med. 2003;9:1413–1417.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.